Over the past decade, remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) have transformed from emerging technologies into integral components of chronic disease management. Fueled by advances in connected medical devices, wearable sensors, digital therapeutics, artificial intelligence (AI), and virtual care platforms, remote monitoring has expanded providers’ ability to manage patients beyond the traditional clinical setting while supporting earlier intervention and improved patient engagement.
The COVID-19 Public Health Emergency accelerated adoption of these technologies, prompting CMS to expand reimbursement opportunities that encouraged providers to integrate remote monitoring into routine clinical care. As adoption increased, an entire ecosystem emerged around these services. Medical device manufacturers evolved beyond hardware, digital health companies developed sophisticated monitoring platforms, and specialized vendors began providing outsourced clinical monitoring services that enabled physician practices to offer RPM and RTM without building extensive internal infrastructure.
Now, CMS appears poised to reevaluate that model.
Within the Calendar Year (CY) 2027 Medicare Physician Fee Schedule (PFS) Proposed Rule, CMS proposes several significant changes to remote monitoring reimbursement. Although early discussion has focused largely on payment reductions, the proposal represents something much larger: a potential shift in how Medicare expects remote monitoring services to be delivered, supervised, and documented.
For healthcare providers, medical device manufacturers, and digital health companies alike, the proposal may signal the next evolution of Medicare’s digital health reimbursement strategy.
The Evolution of Remote Monitoring
Remote monitoring was originally envisioned as a means of extending clinical care into patients’ homes. Connected devices capable of transmitting physiologic measurements—including blood pressure, weight, glucose levels, cardiac rhythm, respiratory status, and therapeutic adherence—allow providers to monitor patients between office visits while identifying changes that may require clinical intervention.
Over time, reimbursement expanded to support not only the collection of physiologic data but also the ongoing clinical management required to interpret those data and engage patients appropriately.
Today’s remote monitoring programs frequently integrate multiple technologies, including:
- FDA-authorized connected medical devices
- Cloud-based data aggregation platforms
- Artificial intelligence and predictive analytics
- Clinical decision support software
- Care coordination workflows
- Patient engagement applications
- Documentation and billing support
- Clinical monitoring personnel
Many physician practices adopted these comprehensive service models because they lacked sufficient staff to perform continuous patient monitoring independently. Outsourced monitoring vendors emerged to bridge that gap by supplying trained clinical personnel who worked under physician supervision while handling routine monitoring activities.
Those outsourced models have become central to many successful RPM programs.
CMS is now questioning whether that approach remains consistent with Medicare’s statutory payment requirements.
CMS’ Proposed Policy Changes
The CY 2027 Proposed Rule includes several noteworthy revisions affecting RPM and RTM.
Among the most significant is CMS’ proposal to limit reimbursement for clinical monitoring services performed by third-party vendors. Under the proposal, Medicare would reimburse these services only when they are furnished by clinical staff employed by the billing practitioner or practice, rather than personnel supplied through outside organizations.
CMS also proposes several additional changes designed to strengthen program integrity and clarify billing requirements, including:
- Requiring an initiating visit before RPM and RTM services begin.
- Limiting RTM services to established patients.
- Replacing existing CPT coding with Medicare-specific HCPCS G-codes tailored to Medicare payment policies.
- Clarifying documentation expectations surrounding supervision and clinical responsibility.
Although each proposal may appear incremental individually, together they represent a meaningful policy shift.
Rather than simply refining reimbursement methodology, CMS appears to be redefining expectations regarding who should perform remote monitoring services and how providers demonstrate accountability.
Why Program Integrity Matters
CMS’ proposal should be viewed within the broader context of Medicare’s increasing focus on program integrity.
Over the past several years, the agency has devoted considerable attention to ensuring that services billed to Medicare reflect direct clinical oversight, appropriate documentation, and clear accountability for patient care. Remote monitoring has experienced rapid utilization growth during that same period, attracting greater scrutiny regarding supervision requirements, vendor relationships, and billing practices.
CMS’ proposed revisions suggest concern that existing reimbursement policies may not sufficiently distinguish between technology vendors supporting clinical care and organizations effectively furnishing billable professional services.
The proposed changes appear intended to reinforce Medicare’s longstanding principle that reimbursable clinical services remain under the direct responsibility of the treating practitioner.
Whether stakeholders ultimately agree with that interpretation will likely become a central topic during the public comment period.
Implications for Providers
For physician practices and health systems, the proposal could create challenges extending well beyond reimbursement.
Organizations relying on outsourced monitoring vendors may need to evaluate whether existing workflows remain compliant should the proposal be finalized. Internal staffing requirements could increase substantially as practices assume greater responsibility for day-to-day patient monitoring activities previously performed externally.
Operational considerations may include:
- Recruiting additional clinical staff
- Developing internal monitoring workflows
- Expanding documentation processes
- Revising contracts with remote monitoring vendors
- Evaluating financial sustainability of existing RPM programs
Smaller physician practices and rural providers may experience disproportionate impact, particularly if they lack resources to build internal monitoring capabilities.
While larger integrated delivery networks may possess greater flexibility, they too may need to reassess staffing models and operational costs associated with remote monitoring.
Implications for Medical Device Manufacturers and Digital Health Companies
Medical device manufacturers may also find themselves navigating a changing reimbursement environment.
Many companies have evolved beyond traditional device manufacturers to become comprehensive digital health organizations offering integrated monitoring solutions. Their value proposition increasingly combines hardware, software, analytics, patient engagement, and clinical monitoring support into a single service offering.
If Medicare limits reimbursement for outsourced monitoring personnel, manufacturers and digital health companies may need to reconsider commercialization strategies that depend on external clinical service models.
Future product development may place greater emphasis on enabling provider-employed staff to perform monitoring activities efficiently rather than relying upon outsourced clinical infrastructure.
Artificial intelligence may play an increasingly important role as organizations seek technology solutions capable of improving workflow efficiency while reducing staffing burdens.
The Intersection of Innovation and Reimbursement
The proposal also illustrates an increasingly important reality across healthcare.
Innovation alone is no longer sufficient.
Whether developing advanced diagnostics, AI-enabled clinical decision support, digital therapeutics, or remote monitoring technologies, organizations must now demonstrate that innovation aligns with evolving reimbursement policy.
Coverage, coding, payment, documentation, and operational implementation have become inseparable components of successful commercialization.
The organizations that succeed will increasingly be those that incorporate reimbursement strategy into product development from the earliest stages rather than treating reimbursement as a downstream consideration.
What Organizations Should Be Doing Now
Although the proposal remains subject to public comment before becoming final, healthcare organizations should begin evaluating its potential operational implications today.
Organizations should consider:
- Identifying which remote monitoring services rely upon outsourced vendors.
- Reviewing staffing models supporting RPM and RTM programs.
- Assessing documentation workflows for compliance with evolving Medicare expectations.
- Modeling potential financial impacts associated with increased internal staffing.
- Evaluating commercialization strategies for digital health products dependent upon outsourced monitoring services.
- Participating in the CMS public comment process to help inform final policy development.
Early planning will position organizations to adapt more effectively should CMS finalize these proposals.
Looking Ahead
Remote monitoring continues to represent one of healthcare’s most promising tools for improving chronic disease management, expanding patient access, and enabling more proactive care.
The CY 2027 Physician Fee Schedule Proposed Rule does not diminish that promise.
Instead, it signals that CMS is refining how it expects these services to fit within Medicare’s reimbursement framework.
Whether the final rule ultimately adopts these proposals in whole or in part, one message is clear: digital health innovation and reimbursement policy are becoming increasingly intertwined.
Organizations that proactively align operational strategy, reimbursement planning, and market access with evolving Medicare policy will be best positioned to sustain growth while continuing to deliver innovative, technology-enabled patient care.
About Clarisa Blattner, CCS, CPC
Clarisa Blattner is the Senior Director of Revenue and Payor Optimization at XiFin, Inc. She serves as a subject matter expert in revenue cycle management (RCM) and payor and market strategies, focusing on achieving operational efficiencies and maximizing revenue. With over 25 years of experience in the healthcare sector, Clarisa has an extensive background in revenue cycle management, particularly within the healthcare industry. Previously, she oversaw the billing and reimbursement operations for the outsourced billing department
